RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
30.14
1.04 (3.57%)
At close: Oct 03, 2025, 3:59 PM
29.50
-2.12%
After-hours: Oct 03, 2025, 07:26 PM EDT
3.57% (1D)
| Bid | 29.5 |
| Market Cap | 498.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.49M |
| EPS (ttm) | -15.63 |
| PE Ratio (ttm) | -1.93 |
| Forward PE | -9.45 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 35 |
| Volume | 530,925 |
| Avg. Volume (20D) | 155,576 |
| Open | 29.26 |
| Previous Close | 29.10 |
| Day's Range | 28.07 - 31.76 |
| 52-Week Range | 5.66 - 31.76 |
| Beta | 0.23 |
| Ex-Dividend Date | n/a |
About RAPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
+110.91%
RAPT Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
10 months ago
-39.45%
RAPT Therapeutics shares are trading lower after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
